Ankara University Faculty of Dentistry
Ankara, 06560, Turkey (Türkiye)
NCT Number: NCT07769125
This prospective observational cohort study evaluated the relationship between peri-implant soft tissue characteristics and early marginal bone loss following dental implant placement. The study included patients receiving bone-level implants in posterior edentulous regions. Keratinized mucosa width, supracrestal tissue height, and mucosal thickness were measured at the time of implant placement. Marginal bone levels were assessed using standardized intraoral radiographs obtained at baseline and three months after implant placement. The primary aim was to determine whether these peri-implant soft tissue dimensions were associated with marginal bone loss during the early healing period.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Observational
Ankara, 06560, Turkey (Türkiye)
This prospective observational cohort study was conducted at the Department of Periodontology, Faculty of Dentistry, Ankara University. Participants requiring implant-supported rehabilitation in posterior edentulous regions were prospectively enrolled and received bone-level dental implants according to a standardized surgical protocol. No participant was assigned to a treatment or exposure group for research purposes.
Peri-implant soft tissue dimensions were clinically assessed at the time of implant placement. Keratinized mucosa width was measured as the distance from the mucogingival junction to the mid-crestal point of the edentulous ridge. Supracrestal tissue height was determined following flap elevation as the vertical distance from the alveolar crest to the free gingival margin. Mucosal thickness was measured horizontally at the mid-buccal aspect using an endodontic file with a silicone stop.
Standardized intraoral periapical radiographs were obtained at implant placement and at the three-month follow-up using a parallel technique with individualized positioning. Radiographic measurements were calibrated according to the known implant length. Marginal bone level was determined on the mesial and distal aspects of each implant relative to the implant platform, and changes between baseline and the three-month follow-up were used to assess early marginal bone remodeling. Radiographic measurements were performed by a calibrated examiner blinded to the clinical soft tissue measurements.
The study was designed to examine the associations between peri-implant soft tissue dimensions and early marginal bone changes during healing after implant placement. Statistical analyses evaluated these relationships using both univariable and multivariable approaches while accounting for the distribution and structure of the collected data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bruxism. Poor oral hygiene. Need for bone augmentation at the implant site.
Time frame: Baseline to 3 months after implant placement
Marginal bone loss was determined from standardized intraoral periapical radiographs obtained at implant placement (baseline) and at the three-month follow-up. Marginal bone level was measured on the mesial and distal aspects of each implant as the distance from the implant platform to the first bone-to-implant contact. Measurements were calibrated using the known implant length. Marginal bone loss was calculated as the change in marginal bone level from baseline to three months, and the mean of the mesial and distal measurements was used for analysis. Higher values indicate greater marginal bone loss.
Karabuk University
Other
Impact of Peri-implant Soft Tissue Phenotype on Early Marginal Bone Loss: A Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07381608
Alveolar Bone Loss in Mandible, Dental Implant
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05890469
Biomarkers, Dental Implant
London, United Kingdom
View Trial DetailsNCT07654452
Dental Implant, Maxillary Tooth Loss
Ismailia, Egypt
View Trial DetailsNCT07665281
Alveolar Bone Loss, Bone Diseases
Hillah, Babylon, Iraq
View Trial Details